Latest Posts Under: Pharma Industry News

US biopharma company Antios Therapeutics has initiated its first-in-human phase 1 clinical trial for ATI-2173, a liver-targeted, orally-administered, small molecule against hepatitis B. The phase 1a study is a randomized, double-blind, placebo-controlled single-ascending dose (SAD) study that will feature healthy volunteers to assess the safety, tolerability and pharmacokinetic profile of the compound. The SAD trial […]

SpeeDx, an Australian clinical diagnostics company, to support improved patient outcomes, has secured $15 million in a Series B funding round from US-based investor Northpond Ventures. The company has developed a molecular diagnostics test portfolio, mainly for infectious diseases, that offers identification and also therapeutic guidance capabilities. Michael P. Rubin – Founder and CEO of […]

PCI Pharma Services, a pharma supply chain solutions provider, has acquired Canada-based pharma packaging company Bellwyck Pharma Services for an undisclosed price. Bellwyck Pharma Services has been serving the clinical trial and commercial drug markets with primary and secondary packaging and labeling for 25 years. Its acquisition will give four GMP-compliant facilities for PCI Pharma […]

Drug manufacturer Catalent Pharma Solutions has wrapped up its previously announced $315 million acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development and manufacturing organization (cell and gene therapy CDMO). The acquisition, which was announced earlier this month, is said to position Catalent as a major technology, development, and manufacturing partner for […]

Olympus Medical Systems Group has secured clearance from the US Food and Drug Administration (FDA) for its TJF-Q190V duodenoscope with a sterile, disposable distal endcap. The latest generation duodenoscope from Olympus is said to have integrated advanced features to enhance cleaning and reprocessing of the endoscopy instrument, in order to help in reducing potential device […]

CytoSorbents has secured approval from the European Union (EU) for its CytoSorb extracorporeal blood purification therapy for the removal of anti-platelet agent ticagrelor during surgery requiring cardiopulmonary bypass (CPB). The CytoSorb whole blood adsorber has also been given CE Mark label expansion for the indication.  It was earlier approved in the European Union for the […]

Aimmune Therapeutics, which has recently bagged approval from the US Food and Drug Administration (FDA) for its peanut allergy drug PALFORZIA (formerly AR101), has secured an additional equity investment of $200 million from Nestlé Health Science. Based in California, Aimmune Therapeutics has been focused on the development and commercialization of treatments for potentially life-threatening food […]

AstraZeneca has signed a deal valued at about $390 million with Atnahs Pharma, a portfolio company of Triton Fund V, to sell five of its hypertension drugs to the latter as they have lost patent protection across the world. The deal will give Atnahs Pharma the global commercial rights to the hypertension medicines – Inderal (propranolol), […]

Novel coronavirus diagnostic test : Co-Diagnostics, a US molecular diagnostics company, said that its research use only (RUO) CoPrimer test for the 2019-nCoV coronavirus is ready for sale to laboratories, hospitals, and institutions. To know about coronavirus symptoms in humans, check here. The molecular diagnostics company claims to have taken two weeks for the design, […]

JanOne has signed a manufacturing agreement with cGMP contract manufacturer CoreRx for the clinical formulation and manufacturing of its lead drug candidate TV1001SR, a potential treatment for peripheral artery disease (PAD). More than 8.5 million people in the US are affected by peripheral artery disease for which currently there are no direct treatments available. Tony […]